Bg pattern

EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Emylif 50mg buccal film

riluzole

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Emylif and what is it used for
  2. What you need to know before taking Emylif
  3. How to take Emylif
  4. Possible side effects
  5. Storage of Emylif
  6. Contents of the pack and further information

1. What is Emylif and what is it used for

What is Emylif

The active substance of Emylif is riluzole, which acts on the nervous system.

What is Emylif used for

Emylif is used in adult patients with amyotrophic lateral sclerosis (ALS).

ALS is a type of motor neuron disease that affects the nerve cells responsible for sending signals to muscles, leading to weakness, muscle loss, and paralysis.

The destruction of nerve cells in motor neuron diseases may be due to an excess of glutamate (a chemical messenger) in the brain and spinal cord. Emylif stops the release of glutamate, which may help prevent damage to nerve cells.

Consult your doctor for more information about ALS and why this medication has been prescribed for you.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Emylif

Do not take Emylif

  • if you are allergic to riluzole or any of the other ingredients of this medication (listed in section 6),
  • if you have any liver disease or elevated blood levels of certain liver enzymes (transaminases),
  • if you are pregnant or breastfeeding.

Warnings and precautions

Consult your doctor before taking Emylif:

  • if you have any liver problems: yellowing of the skin or whites of the eyes (jaundice), generalized itching, dizziness, nausea;
  • if your kidneys do not function properly;
  • if you have a fever: it may be due to a decrease in the number of white blood cells, which can increase the risk of infection;
  • if you experience excessive drooling or severe swallowing difficulties.

If you are in any of the above situations or are unsure, consult your doctor for advice on what to do.

Children and adolescents

The use of this medication is not recommended in children under 18 years of age, as there is no information available for this population.

Other medications and Emylif

Tell your doctor if you are taking, have recently taken, or may take any other medications.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or think you may be pregnant, DO NOT take this medication.

If you are planning to become pregnant or breastfeed, consult your doctor before taking this medication.

Driving and using machines

You can drive and use all types of machines and tools, unless you experience dizziness or drowsiness after taking this medication.

Emylif contains:

  • 2 mg of fructose in each buccal film. Fructose can damage teeth.
  • Orange Yellow S (E110). May cause allergic reactions.

3. How to take Emylif

Follow the administration instructions for this medication exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.

The recommended dose is one buccal film twice a day.

The buccal film should be taken orally, every 12 hours, at the same time each day (e.g., morning and night).

After taking this medication, you may experience a decrease in oral sensitivity after 1 minute. Until this sensation disappears, which usually takes about 40 minutes, be cautious when consuming food.

Method of administration:

The following are the oral administration instructions.

Step 1. Before taking Emylif

  • Make sure your hands are clean and dry before handling this medication to prevent the film from sticking to your fingers.
  • Before use, check the expiration date printed on the aluminum sachet, as shown in Figure 1.

Do nottake this medication if it has expired.

Rectangular black auto-injector device with transparent window and two red circles highlighting its size

Figure 1

Step 2. Open the sachet

  • Fold the aluminum sachet along the continuous line at the top, as shown in Figure 2.
  • While keeping the top of the sachet folded along the continuous line, pull down the lateral opening in the direction of the arrow to open the sachet.

Broken glass ampoule showing liquid extraction with a red arrow indicating the direction

Figure 2

Step 3. Remove the film

  • Remove the Emylif film from the aluminum sachet. Each sachet contains one dose of Emylif.
  • Do notfold the Emylif film.

Hand holding an applicator device with a short needle protruding from one end for subcutaneous injection

Figure 3

Step 4. Place the film on your tongue

  • Place the Emylif film on your tongue, as shown in Figure 4. The film will stick to your tongue and start to dissolve.

Hand placing a sublingual tablet under the tongue with the mouth slightly open

Figure 4

Step 5. Close your mouth and swallow saliva normally

  • Close your mouth as shown in Figure 5 and swallow saliva normally while the medication dissolves over 3 minutes.
  • Do nottake this medication with liquids.
  • Do notchew, spit, or talk while the medication is dissolving.

Facial profile showing the jaw and neck area with a light gray tone

Figure 5

Step 6. After administering Emylif, wash your hands

If you take more Emylif than you should

If you take too many buccal films, contact your doctor or go to the emergency department of the nearest hospital immediately.

If you forget to take Emylif

If you forget to take a buccal film, skip it and take the next one at the usual time.

Do not take a double dose to make up for the forgotten dose.

If you have any further questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

IMPORTANT

Tell your doctor immediately

  • if you have a fever (increased body temperature), as this medication may reduce the number of white blood cells. Your doctor may advise you to have a blood test to check your white blood cell count, as they are important for fighting infections;
  • if you experience any of the following symptoms: yellowing of the skin or whites of the eyes (jaundice), generalized itching, dizziness, or nausea, as they may be signs of liver disease (hepatitis). Your doctor may recommend that you have regular blood tests while taking Emylif to ensure this does not occur;
  • if you have a cough or difficulty breathing, as they may be signs of lung disease (interstitial lung disease).

Other side effects

Very common side effects(may affect more than 1 in 10 people) of this medication are:

  • fatigue
  • dizziness
  • increased blood levels of certain liver enzymes (transaminases)
  • decreased oral sensitivity

Common side effects(may affect up to 1 in 10 people) of this medication are:

  • dizziness
  • numbness or tingling in the mouth
  • vomiting
  • drowsiness
  • increased heart rate
  • diarrhea
  • headache
  • abdominal pain
  • pain

Uncommon side effects(may affect up to 1 in 100 people) of this medication are:

  • anemia
  • allergic reactions
  • pancreatitis (inflammation of the pancreas)

Side effect of unknown frequency(cannot be estimated from available data) of this medication is:

  • skin rash

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Emylif

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the sachet and carton after "EXP". The expiration date is the last day of the month indicated.

Store below 30°C.

Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Contents of the pack and further information

Composition of Emylif

  • The active substance is riluzole.
  • The other ingredients are:

polacrilin, pullulan (E1204), xylitol (E967), hypromellose (E464), glycerol (E422), glycerol monooleate, sucralose (E955), fructose, macrogol, honey flavor, xanthan gum, lemon flavor, orange yellow S (E110), white ink (purified water, titanium dioxide [E171], propylene glycol [E1520], hypromellose [E464], isopropyl alcohol, ethanol, and methanol).

Insufficient levels of the antioxidant butylated hydroxytoluene (E321).

Appearance of the product and pack contents

Buccal film:

Thin, rectangular, orange-colored buccal film (32 mm x 22 mm) with "R50" printed in white on one side.

Emylif is available in packs of 14, 28, 56, 98, 112, and 140 buccal films for oral administration.

Each carton contains 14, 28, 56, 98, 112, and 140 sachets.

Not all pack sizes may be marketed.

Marketing authorization holder

Zambon S.p.A.

Via Lillo del Duca 10

20091 Bresso (MI), Italy

Phone: +39 02665241

Fax: +39 02 66501492

Email: [email protected]

Manufacturer

Zambon S.p.A.

Via della Chimica, 9

36100 Vicenza

Italy

You can request more information about this medication from the local representative of the marketing authorization holder:

Zambon, S.A.U.

Maresme 5

Polígono Can Bernades - Subirà

08130 Santa Perpetua de Mogoda (Barcelona) Spain

Phone: +34 93 544 64 00

This medication is authorized in the EEA member states under the following names:

Emylif: Austria, Belgium, Denmark, Finland, France, Germany, Iceland, Italy, Luxembourg, Norway, Portugal, Spain, Sweden, Netherlands.

Date of last revision of this package leaflet: October 2022

Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS): http://www.aemps.gob.es/

Online doctors for EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS

Discuss questions about EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
0.0 (1)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations.

In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life.

Patients consult Dr Daria Portnova for the following concerns:

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.
Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.
Camera Book a video appointment
€110
5.0 (77)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€89
5.0 (137)
Doctor

Taisiia Proida

Psychiatry 7 years exp.

Dr. Taisiia Proida is a psychiatrist and cognitive behavioural therapist (CBT), and a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care.

She specialises in consultations and ongoing support for a wide range of mental health concerns, including:

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders.

She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Camera Book a video appointment
€120

Frequently Asked Questions

Is a prescription required for EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS?
EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS?
The active ingredient in EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS is riluzole. This information helps identify medicines with the same composition but different brand names.
Who manufactures EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS?
EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS is manufactured by Zambon S.P.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to EMYLIF 50 mg ORALLY DISINTEGRATING TABLETS?
Other medicines with the same active substance (riluzole) include RILUTEK 50 mg FILM-COATED TABLETS, RILUZOL AUROVITAS 50 mg FILM-COATED TABLETS, RILUZOL PMCS 50 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media